Over the past several years, Kenya's in vitro diagnostics (IVD) market has demonstrated impressive advancements, fueled by a confluence of technological innovations and an increasing need to address infectious and chronic diseases. The high prevalence of diseases like HIV, tuberculosis (TB), and
The In Vitro Diagnostics (IVD) market in India is positioned for remarkable growth, projected to expand from USD 2.64 billion in 2024 to an impressive USD 4.77 billion by 2034. This anticipated development reflects a robust compound annual growth rate (CAGR) of 6.10%. As advancements in molecular
The global hepatitis testing market is on a trajectory poised for significant growth, driven by several dynamic factors reshaping this critical aspect of healthcare. The sector is projected to grow from a valuation of USD 3.53 billion in 2023, soaring to USD 5.75 billion by 2032. Such robust
The world of in vitro diagnostics (IVD) is rapidly transforming, driven by the urgent need for accurate and timely diagnostic solutions in the healthcare sector. At the heart of this evolution lies the IVD Contract Manufacturing Services Market, a critical component in the healthcare supply chain.
In a significant advancement for Alzheimer's diagnostics, Quest Diagnostics is set to launch an FDA-approved blood test designed to detect amyloid pathology with remarkable precision. This pioneering test, developed by Fujirebio Diagnostics, represents a milestone as it receives FDA clearance,
The Clinical Reference Laboratory Service Market stands at the forefront of modern healthcare, set for remarkable growth with estimations suggesting a USD 25.8 billion valuation by 2032, propelled by a 5.11% CAGR. The significance of this growth lies in diagnostic testing, rapidly becoming a
